{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:22:53Z","timestamp":1763634173765,"version":"3.45.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40122-025-00783-x","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T03:00:59Z","timestamp":1760151659000},"page":"1687-1709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-Management Strategies for Treating Pediatric and Adolescent Headaches and Migraines with Over-the-Counter Molecules: Expert Opinion and Literature Review"],"prefix":"10.1007","volume":"14","author":[{"given":"Christopher","family":"Oakley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1058-4962","authenticated-orcid":false,"given":"Preeti","family":"Kachroo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashoke","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"783_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211\u201359.","journal-title":"Lancet"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0038-1646946","volume":"38","author":"D Saylor","year":"2018","unstructured":"Saylor D, Steiner T. The global burden of headache. Semin Neurol. 2018;38:182\u201390. https:\/\/doi.org\/10.1055\/s-0038-1646946.","journal-title":"Semin Neurol"},{"key":"783_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11916-013-0341-z","volume":"17","author":"\u00c7 W\u00f6ber-Bing\u00f6l","year":"2013","unstructured":"W\u00f6ber-Bing\u00f6l \u00c7. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep. 2013;17:341. https:\/\/doi.org\/10.1007\/s11916-013-0341-z.","journal-title":"Curr Pain Headache Rep"},{"key":"783_CR4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1469-8749.2010.03793.x","volume":"52","author":"I Abu-Arafeh","year":"2010","unstructured":"Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52:1088\u201397. https:\/\/doi.org\/10.1111\/j.1469-8749.2010.03793.x.","journal-title":"Dev Med Child Neurol"},{"key":"783_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11916-020-00892-6","volume":"24","author":"V Nieswand","year":"2020","unstructured":"Nieswand V, Richter M, Gossrau G. Epidemiology of headache in children and adolescents\u2014another type of pandemia. Curr Pain Headache Rep. 2020;24:62. https:\/\/doi.org\/10.1007\/s11916-020-00892-6.","journal-title":"Curr Pain Headache Rep"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.112.1.e1","volume":"112","author":"SW Powers","year":"2003","unstructured":"Powers SW, Patton SR, Hommel KA, Hershey AD, American Academy of Pediatrics. Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics. 2003;112:e1-5.","journal-title":"Pediatrics"},{"key":"783_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1468-2982.2004.00652.x","volume":"24","author":"S Powers","year":"2004","unstructured":"Powers S, Patton S, Hommel K, Hershey A. Quality of life in paediatric migraine: characterization of age-related effects using PedsQL 4.0. Cephalalgia. 2004;24:120\u20137. https:\/\/doi.org\/10.1111\/j.1468-2982.2004.00652.x.","journal-title":"Cephalalgia"},{"key":"783_CR8","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/head.12394","volume":"54","author":"PAS Rocha-Filho","year":"2014","unstructured":"Rocha-Filho PAS, Santos PV. Headaches, quality of life, and academic performance in schoolchildren and adolescents. Headache. 2014;54:1194\u2013202. https:\/\/doi.org\/10.1111\/head.12394.","journal-title":"Headache"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s10194-019-1050-8","volume":"20","author":"J Philipp","year":"2019","unstructured":"Philipp J, Zeiler M, W\u00f6ber C, et al. Prevalence and burden of headache in children and adolescents in Austria \u2013 a nationwide study in a representative sample of pupils aged 10\u201318\u00a0years. J Headache Pain. 2019;20:101. https:\/\/doi.org\/10.1186\/s10194-019-1050-8.","journal-title":"J Headache Pain"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1129-2377-15-86","volume":"15","author":"\u00c7 W\u00f6ber-Bing\u00f6l","year":"2014","unstructured":"W\u00f6ber-Bing\u00f6l \u00c7, W\u00f6ber C, Uluduz D, et al. The global burden of headache in children and adolescents \u2013 developing a questionnaire and methodology for a global study. J Headache Pain. 2014;15:86. https:\/\/doi.org\/10.1186\/1129-2377-15-86.","journal-title":"J Headache Pain"},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2014.02.022","volume":"51","author":"JM Dooley","year":"2014","unstructured":"Dooley JM, Augustine HF, Brna PM, Digby AM. The prognosis of pediatric headaches\u2014a 30-year follow-up study. Pediatr Neurol. 2014;51:85\u20137.","journal-title":"Pediatr Neurol"},{"key":"783_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016670","volume":"7","author":"K Probyn","year":"2017","unstructured":"Probyn K, Bowers H, Mistry D, et al. Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components. BMJ Open. 2017;7:e016670.","journal-title":"BMJ Open"},{"key":"783_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s13311-018-0623-6","volume":"15","author":"F Puledda","year":"2018","unstructured":"Puledda F, Shields K. Non-pharmacological approaches for migraine. Neurotherapeutics. 2018;15:336\u201345. https:\/\/doi.org\/10.1007\/s13311-018-0623-6.","journal-title":"Neurotherapeutics"},{"key":"783_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17114126","volume":"17","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2020","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Florencio LL, Plaza-Manzano G, Arias-Bur\u00eda JL. Clinical reasoning behind non-pharmacological interventions for the management of headaches: a narrative literature review. Int J Environ Res Public Health. 2020;17:4126.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"783_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10194-010-0266-4","volume":"12","author":"G Haag","year":"2011","unstructured":"Haag G, Diener H-C, May A, et al. Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migr\u00e4ne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft f\u00fcr Neurologie (DGN), the \u00d6sterreichische Kopfschmerzgesellschaft (\u00d6KSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain. 2011;12(2):201\u201317. https:\/\/doi.org\/10.1007\/s10194-010-0266-4.","journal-title":"J Headache Pain"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/head.12499","volume":"55","author":"MJ Marmura","year":"2015","unstructured":"Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55:3\u201320. https:\/\/doi.org\/10.1111\/head.12499.","journal-title":"Headache"},{"key":"783_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/14656566.2018.1552941","volume":"20","author":"P Barbanti","year":"2019","unstructured":"Barbanti P, Grazzi L, Egeo G. Pharmacotherapy for acute migraines in children and adolescents. Expert Opin Pharmacother. 2019;20:455\u201363. https:\/\/doi.org\/10.1080\/14656566.2018.1552941.","journal-title":"Expert Opin Pharmacother"},{"key":"783_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1212\/WNL.0000000000008095","volume":"93","author":"M Oskoui","year":"2019","unstructured":"Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: acute treatment of migraine in children and adolescents: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93:487\u201399. https:\/\/doi.org\/10.1212\/WNL.0000000000008095.","journal-title":"Neurology"},{"key":"783_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/PHMT.S334744","volume":"13","author":"RC Gibler","year":"2022","unstructured":"Gibler RC, Knestrick KE, Reidy BL, Lax DN, Powers SW. Management of chronic migraine in children and adolescents: where are we in 2022? Pediatr Health Med Ther. 2022;13:309\u201323. https:\/\/doi.org\/10.2147\/PHMT.S334744.","journal-title":"Pediatr Health Med Ther"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s40263-016-0375-y","volume":"30","author":"J Kacperski","year":"2016","unstructured":"Kacperski J, Hershey AD. Newly approved agents for the treatment and prevention of pediatric migraine. CNS Drugs. 2016;30:837\u201344. https:\/\/doi.org\/10.1007\/s40263-016-0375-y.","journal-title":"CNS Drugs"},{"key":"783_CR21","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1212\/01.WNL.0000147332.41993.90","volume":"63","author":"D Lewis","year":"2004","unstructured":"Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents [RETIRED]: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215\u201324. https:\/\/doi.org\/10.1212\/01.WNL.0000147332.41993.90.","journal-title":"Neurology"},{"key":"783_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ncl.2008.11.003","volume":"27","author":"DW Lewis","year":"2009","unstructured":"Lewis DW. Pediatric migraine. Neurol Clin. 2009;27:481\u2013501.","journal-title":"Neurol Clin"},{"key":"783_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.acap.2010.04.002","volume":"10","author":"KM Wilson","year":"2010","unstructured":"Wilson KM, Singh P, Blumkin AK, Dallas L, Klein JD. Knowledge gaps and misconceptions about over-the-counter analgesics among adolescents attending a hospital-based clinic. Acad Pediatr. 2010;10:228\u201332.","journal-title":"Acad Pediatr"},{"key":"783_CR24","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1586\/ern.12.104","volume":"12","author":"I Toldo","year":"2012","unstructured":"Toldo I, De Carlo D, Bolzonella B, Sartori S, Battistella PA. The pharmacological treatment of migraine in children and adolescents: an overview. Expert Rev Neurother. 2012;12:1133\u201342. https:\/\/doi.org\/10.1586\/ern.12.104.","journal-title":"Expert Rev Neurother"},{"key":"783_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12098-020-03437-2","volume":"88","author":"PK Panda","year":"2021","unstructured":"Panda PK, Sharawat IK. Paracetamol versus ibuprofen for the acute treatment of migraine headache in children: a blinded randomized controlled trial\u2014correspondence. Indian J Pediatr. 2021;88:207\u20138. https:\/\/doi.org\/10.1007\/s12098-020-03437-2.","journal-title":"Indian J Pediatr"},{"key":"783_CR26","first-page":"1","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia. 2004;24:1\u2013160.","journal-title":"Cephalalgia"},{"key":"783_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s11916-002-0082-x","volume":"6","author":"M Vandenheede","year":"2002","unstructured":"Vandenheede M, Schoenen J. Central mechanisms in tension-type headaches. Curr Pain Headache Rep. 2002;6:392\u2013400. https:\/\/doi.org\/10.1007\/s11916-002-0082-x.","journal-title":"Curr Pain Headache Rep"},{"key":"783_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1468-2982.2003.00574.x","volume":"23","author":"R Jensen","year":"2003","unstructured":"Jensen R. Peripheral and central mechanisms in tension-type headache: an update. Cephalalgia. 2003;23:49\u201352. https:\/\/doi.org\/10.1046\/j.1468-2982.2003.00574.x.","journal-title":"Cephalalgia"},{"key":"783_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11916-005-0021-8","volume":"9","author":"S Ashina","year":"2005","unstructured":"Ashina S, Bendtsen L, Ashina M. Pathophysiology of tension-type headache. Curr Pain Headache Rep. 2005;9:415\u201322. https:\/\/doi.org\/10.1007\/s11916-005-0021-8.","journal-title":"Curr Pain Headache Rep"},{"key":"783_CR30","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","volume":"35","author":"R Burstein","year":"2015","unstructured":"Burstein R, Noseda R, Borsook D, Society for Neuroscience. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35:6619\u201329.","journal-title":"J Neurosci"},{"key":"783_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1542\/pir.33.12.562","volume":"33","author":"HK Blume","year":"2012","unstructured":"Blume HK, American Academy of Pediatrics. Pediatric headache: a review. Pediatr Rev. 2012;33:562\u201376.","journal-title":"Pediatr Rev"},{"key":"783_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9091(05)80021-X","author":"AD Rothner","year":"1995","unstructured":"Rothner AD. The evaluation of headaches in children and adolescents. Semin Pediatr Neurol. 1995. https:\/\/doi.org\/10.1016\/S1071-9091(05)80021-X.","journal-title":"Semin Pediatr Neurol"},{"key":"783_CR33","first-page":"181","volume":"98","author":"N McCrea","year":"2013","unstructured":"McCrea N, Howells R, Royal College of Paediatrics and Child Health. Fifteen minute consultation: headache in children under 5\u00a0years of age. Arch Dis Child. 2013;98:181\u20135.","journal-title":"Arch Dis Child"},{"key":"783_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11916-009-0048-3","volume":"13","author":"ME Bigal","year":"2009","unstructured":"Bigal ME, Lipton RB. Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep. 2009;13:301\u20137. https:\/\/doi.org\/10.1007\/s11916-009-0048-3.","journal-title":"Curr Pain Headache Rep"},{"key":"783_CR35","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1080\/20786190.2019.1610228","volume":"61","author":"R Van Rensburg","year":"2019","unstructured":"Van Rensburg R, Reuter H. An overview of analgesics: NSAIDs, paracetamol, and topical analgesics Part 1. South Afr Fam Pract. 2019;61:S4-10. https:\/\/doi.org\/10.1080\/20786190.2019.1610228.","journal-title":"South Afr Fam Pract"},{"key":"783_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00045391-200501000-00008","volume":"12","author":"GG Graham","year":"2005","unstructured":"Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther LWW. 2005;12:46\u201355.","journal-title":"Am J Ther LWW"},{"key":"783_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1527-3458.2006.00250.x","volume":"12","author":"A Bertolini","year":"2006","unstructured":"Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12:250\u201375. https:\/\/doi.org\/10.1111\/j.1527-3458.2006.00250.x.","journal-title":"CNS Drug Rev"},{"key":"783_CR38","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1460-9592.2008.02764.x","volume":"18","author":"BJ Anderson","year":"2008","unstructured":"Anderson BJ. Paracetamol (acetaminophen): mechanisms of action. Pediatr Anesth. 2008;18:915\u201321. https:\/\/doi.org\/10.1111\/j.1460-9592.2008.02764.x.","journal-title":"Pediatr Anesth"},{"key":"783_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","volume":"21","author":"GG Graham","year":"2013","unstructured":"Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21:201\u201332. https:\/\/doi.org\/10.1007\/s10787-013-0172-x.","journal-title":"Inflammopharmacology"},{"key":"783_CR40","first-page":"153","volume":"14","author":"CV Sharma","year":"2014","unstructured":"Sharma CV, Mehta V. Paracetamol: mechanisms and updates. Contin Educ Anaesth Crit Care Pain. 2014;14:153\u20138.","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"783_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5694\/mja2.50992","volume":"214","author":"C Abdel Shaheed","year":"2021","unstructured":"Abdel Shaheed C, Ferreira GE, Dmitritchenko A, et al. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews. Med J Aust. 2021;214:324\u201331. https:\/\/doi.org\/10.5694\/mja2.50992.","journal-title":"Med J Aust"},{"key":"783_CR42","unstructured":"Paracetamol. Drug information, indications & other medicaments on Catalog.md\u2014GlaxoSmithKline. https:\/\/www.catalog.md\/drugs\/paracetamol-glaxosmithkline.html. Accessed 29 Aug 2025."},{"key":"783_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d2218","author":"RE Ferner","year":"2011","unstructured":"Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning. BMJ. 2011. https:\/\/doi.org\/10.1136\/bmj.d2218.","journal-title":"BMJ"},{"key":"783_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1568010043483980","volume":"3","author":"N Voilley","year":"2004","unstructured":"Voilley N. Acid-sensing ion channels (ASICs): new targets for the analgesic effects of non-steroid anti-inflammatory drugs (NSAIDs). Current Drug Target Inflamm Allergy. 2004;3:71\u20139. https:\/\/doi.org\/10.2174\/1568010043483980.","journal-title":"Current Drug Target Inflamm Allergy"},{"key":"783_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00003495-199600525-00004","volume":"52","author":"JN Cashman","year":"1996","unstructured":"Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52:13\u201323. https:\/\/doi.org\/10.2165\/00003495-199600525-00004.","journal-title":"Drugs"},{"key":"783_CR46","doi-asserted-by":"publisher","first-page":"865","DOI":"10.23736\/S0375-9393.18.12607-1","volume":"84","author":"PH Vuilleumier","year":"2018","unstructured":"Vuilleumier PH, Schliessbach J, Curatolo M. Current evidence for central analgesic effects of NSAIDs: an overview of the literature. Minerva Anestesiol. 2018;84:865\u201370.","journal-title":"Minerva Anestesiol"},{"key":"783_CR47","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.3390\/ph3061966","volume":"3","author":"A Pardutz","year":"2010","unstructured":"Pardutz A, Schoenen J, MDPI. Nsaids in the acute treatment of migraine: a review of clinical and experimental data. Pharmaceuticals. 2010;3:1966\u201387.","journal-title":"Pharmaceuticals"},{"key":"783_CR48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769\u201379.","journal-title":"Lancet"},{"key":"783_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4102\/safp.v57i3.4285","volume":"57","author":"GS Tarr","year":"2015","unstructured":"Tarr GS, Reuter H. Review of the safety of nonsteroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors. S Afr Fam Pract. 2015;57:18\u201321.","journal-title":"S Afr Fam Pract"},{"key":"783_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","volume":"63","author":"RL Howard","year":"2007","unstructured":"Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136\u201347. https:\/\/doi.org\/10.1111\/j.1365-2125.2006.02698.x.","journal-title":"Br J Clin Pharmacol"},{"key":"783_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2165\/00148581-200709030-00008","volume":"9","author":"K Schr\u00f6r","year":"2007","unstructured":"Schr\u00f6r K. Aspirin and Reye syndrome: a review of the evidence. Pediatr Drugs. 2007;9:195\u2013204. https:\/\/doi.org\/10.2165\/00148581-200709030-00008.","journal-title":"Pediatr Drugs"},{"key":"783_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ejpain.2011.08.009","volume":"16","author":"RA Moore","year":"2012","unstructured":"Moore RA, Derry CJ, Derry S, Straube S, McQuay HJ. A conservative method of testing whether combination analgesics produce additive or synergistic effects using evidence from acute pain and migraine. Eur J Pain. 2012;16:585\u201391. https:\/\/doi.org\/10.1016\/j.ejpain.2011.08.009.","journal-title":"Eur J Pain"},{"key":"783_CR53","doi-asserted-by":"publisher","first-page":"CD008659","DOI":"10.1002\/14651858.CD010794.pub2\/abstract","volume":"9","author":"RA Moore","year":"2015","unstructured":"Moore RA, Wiffen PJ, Derry S, Maguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain-an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;9:CD008659. https:\/\/doi.org\/10.1002\/14651858.CD010794.pub2\/abstract.","journal-title":"Cochrane Database Syst Rev"},{"key":"783_CR54","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.33193","volume":"6","author":"A Baratloo","year":"2016","unstructured":"Baratloo A, Rouhipour A, Forouzanfar MM, Safari S, Amiri M, Negida A. The role of caffeine in pain management: a brief literature review. Anesthesiol Pain Med. 2016;6:e33193.","journal-title":"Anesthesiol Pain Med"},{"key":"783_CR55","doi-asserted-by":"publisher","first-page":"CD009281","DOI":"10.1002\/14651858.CD009281.pub3\/abstract","volume":"12","author":"CJ Derry","year":"2014","unstructured":"Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;12:CD009281. https:\/\/doi.org\/10.1002\/14651858.CD009281.pub3\/abstract.","journal-title":"Cochrane Database Syst Rev"},{"key":"783_CR56","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2165\/00002018-200124150-00004","volume":"24","author":"W-Y Zhang","year":"2001","unstructured":"Zhang W-Y. A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Saf. 2001;24:1127\u201342. https:\/\/doi.org\/10.2165\/00002018-200124150-00004.","journal-title":"Drug Saf"},{"key":"783_CR57","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/S0028-3908(00)00045-9","volume":"39","author":"BL Fiebich","year":"2000","unstructured":"Fiebich BL, Lieb K, H\u00fcll M, et al. Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E2 synthesis in rat microglial cells. Neuropharmacology. 2000;39:2205\u201313.","journal-title":"Neuropharmacology"},{"key":"783_CR58","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1185\/030079907X182239","volume":"23","author":"Z Ali","year":"2007","unstructured":"Ali Z, Burnett I, Eccles R, et al. Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea. Curr Med Res Opin. 2007;23:841\u201351. https:\/\/doi.org\/10.1185\/030079907X182239.","journal-title":"Curr Med Res Opin"},{"key":"783_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0887-8994(02)00466-6","volume":"28","author":"JG Millichap","year":"2003","unstructured":"Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol. 2003;28:9\u201315.","journal-title":"Pediatr Neurol"},{"key":"783_CR60","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1046\/j.1468-2982.2003.00576.x","volume":"23","author":"R Hering-Hanit","year":"2003","unstructured":"Hering-Hanit R, Gadoth N. Caffeine-induced headache in children and adolescents. Cephalalgia. 2003;23:332\u20135. https:\/\/doi.org\/10.1046\/j.1468-2982.2003.00576.x.","journal-title":"Cephalalgia"},{"key":"783_CR61","doi-asserted-by":"publisher","first-page":"CD008040","DOI":"10.1002\/14651858.CD008040.pub2\/abstract","volume":"4","author":"S Derry","year":"2010","unstructured":"Derry S, Moore RA, McQuay HJ. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010;4:CD008040. https:\/\/doi.org\/10.1002\/14651858.CD008040.pub2\/abstract.","journal-title":"Cochrane Database Syst Rev"},{"key":"783_CR62","doi-asserted-by":"publisher","first-page":"CD009455","DOI":"10.1002\/14651858.CD009455.pub2\/abstract","volume":"10","author":"S Law","year":"2013","unstructured":"Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;10:CD009455. https:\/\/doi.org\/10.1002\/14651858.CD009455.pub2\/abstract.","journal-title":"Cochrane Database Syst Rev"},{"key":"783_CR63","doi-asserted-by":"publisher","first-page":"CD008039","DOI":"10.1002\/14651858.CD008039.pub3\/abstract","volume":"4","author":"R Rabbie","year":"2013","unstructured":"Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;4:CD008039. https:\/\/doi.org\/10.1002\/14651858.CD008039.pub3\/abstract.","journal-title":"Cochrane Database Syst Rev"},{"key":"783_CR64","doi-asserted-by":"publisher","first-page":"CD008042","DOI":"10.1002\/14651858.CD008041.pub2\/abstract","volume":"4","author":"V Kirthi","year":"2010","unstructured":"Kirthi V, Derry S, Moore RA, McQuay HJ. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010;4:CD008042. https:\/\/doi.org\/10.1002\/14651858.CD008041.pub2\/abstract.","journal-title":"Cochrane Database Syst Rev"},{"key":"783_CR65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2019.06.011","volume":"103","author":"A Talai","year":"2020","unstructured":"Talai A, Heilbrunn B. Ondansetron for acute migraine in the pediatric emergency department. Pediatr Neurol. 2020;103:52\u20136.","journal-title":"Pediatr Neurol"},{"key":"783_CR66","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajem.2010.12.020","volume":"30","author":"ED Trottier","year":"2012","unstructured":"Trottier ED, Bailey B, Lucas N, Lortie A. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Am J Emerg Med. 2012;30:456\u201363.","journal-title":"Am J Emerg Med"},{"key":"783_CR67","unstructured":"World Health Organization. WHO model list of essential medicines: 21st list (2019). https:\/\/policycommons.net\/artifacts\/540967\/world-health-organization-model-list-of-essential-medicines\/1517875\/. Accessed 26 Aug 2025."},{"key":"783_CR68","unstructured":"DailyMed - CHILDRENS ADVIL- ibuprofen suspension. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=3079d932-afb2-94fe-f4ba-a3d8b5198fce. Accessed 26 Aug 2025."},{"key":"783_CR69","unstructured":"DailyMed - JUNIOR STRENGTH ADVIL- ibuprofen tablet, chewable. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=07d4c400-b182-92f7-7574-9e0e94c39cce. Accessed 28 Aug 2025."},{"key":"783_CR70","unstructured":"Brufen Dosage & Drug Information | MIMS Singapore. https:\/\/www.mims.com\/singapore\/drug\/info\/brufen\/. Accessed 26 Aug 2025."},{"key":"783_CR71","unstructured":"Children\u2019s MOTRIN\u00ae Oral Suspension | MOTRIN\u00ae. https:\/\/www.motrin.com\/products\/childrens-motrin. Accessed 26 Aug 2025."},{"key":"783_CR72","unstructured":"Administration (TGA) TG. OTC medicine monograph: ibuprofen for oral use | Therapeutic Goods Administration (TGA). Therapeutic Goods Administration (TGA); 2022. https:\/\/www.tga.gov.au\/how-we-regulate\/supply-therapeutic-good\/supply-non-prescription-medicine\/requirements-otc-new-medicines-n2-applications-using-otc-medicine-monographs\/otc-medicine-monograph-ibuprofen-oral-use. Accessed 26 Aug 2025."},{"key":"783_CR73","unstructured":"Nurofen 200mg tablets. https:\/\/www.nurofen.co.uk\/products\/nurofen-200mg-tablets\/. Accessed 26 Aug 2025."},{"key":"783_CR74","unstructured":"Nurofen Express 400mg maximum strength tablets. https:\/\/www.nurofen.ie\/products\/adult\/nurofen-express-maximum-strength-400mg-tablets\/. Accessed 26 Aug 2025."},{"key":"783_CR75","unstructured":"Nurofen for children: dosages and ingredients | Full Prescribing Info | MIMS Malaysia. https:\/\/www.mims.com\/malaysia\/drug\/info\/nurofen-for-children?type=full. Accessed 26 Aug 2025."},{"key":"783_CR76","unstructured":"Nurofen for children orange singles - Patient Information Leaflet (PIL) - (emc) | 5641. https:\/\/www.medicines.org.uk\/emc\/product\/5641\/pil#companyDetails. Accessed 26 Aug 2025."},{"key":"783_CR77","unstructured":"Nurofen for headaches and pain relief | Nurofen Singapore. https:\/\/www.nurofen.com.sg\/our-products\/children\/nurofen-children-100mg-5ml-oral-suspension\/. Accessed 26 Aug 2025."},{"key":"783_CR78","unstructured":"Pfizer Consumer Healthcare. Advil Product Monograph. Pfizer Consumer Healthcare; 2017. https:\/\/pdf.hres.ca\/dpd_pm\/00039825.PDF. Accessed 29 Aug 2025."},{"key":"783_CR79","unstructured":"Package leaflet: Ibuprofen 200\u00a0mg Film-coated tablets, Ibuprofen 400\u00a0mg Film-coated tablets. https:\/\/www.medicines.org.uk\/emc\/files\/pil.7020.pdf."},{"key":"783_CR80","unstructured":"Anadin Original - Patient Information Leaflet (PIL) - (emc) | 11895. https:\/\/www.medicines.org.uk\/emc\/product\/11895\/pil. Accessed 26 Aug 2025."},{"key":"783_CR81","unstructured":"OTC Medicine Monograph: aspirin tablets for oral use."},{"key":"783_CR82","unstructured":"Aspirin: uses, dosage, side effects and more | MIMS Singapore. https:\/\/www.mims.com\/singapore\/drug\/info\/aspirin. Accessed 26 Aug 2025."},{"key":"783_CR83","unstructured":"Australian Product Information \u2013 ANAPROX\u00ae 550 (naproxen sodium). https:\/\/medsinfo.com.au\/api\/documents\/Anaprox_PI?format=pdf."},{"key":"783_CR84","unstructured":"Bayer Inc. Aleve Product Monograph. 2024. https:\/\/www.bayer.com\/sites\/default\/files\/2020-11\/aleve-pm-en.pdf."},{"key":"783_CR85","unstructured":"Bayer Inc. Maxidol Product Monograph. 2021. https:\/\/www.bayer.com\/sites\/default\/files\/2020-11\/maxidol-pm.pdf. Accessed 29 Aug 2025."},{"key":"783_CR86","unstructured":"Classification of Naproxen. https:\/\/medsafe.govt.nz\/profs\/class\/Agendas\/Agen70\/6.1e_Naproxen.pdf."},{"key":"783_CR87","unstructured":"Summary of product characteristics Naproxen Krka 550\u00a0mg film-coated tablets. https:\/\/assets.hpra.ie\/products\/Human\/26814\/6251c5b8-c9ff-49d6-834d-15afeee9fcd4.pdf."},{"key":"783_CR88","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10194-010-0205-4","volume":"11","author":"L Papetti","year":"2010","unstructured":"Papetti L, Spalice A, Nicita F, et al. Migraine treatment in developmental age: guidelines update. J Headache Pain. 2010;11:267\u201376. https:\/\/doi.org\/10.1007\/s10194-010-0205-4.","journal-title":"J Headache Pain"},{"key":"783_CR89","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1129-2377-15-2","volume":"15","author":"M Lanteri-Minet","year":"2014","unstructured":"Lanteri-Minet M, Valade D, Geraud G, Lucas C, Donnet A. Revised French guidelines for the diagnosis and management of migraine in adults and children. J Headache Pain. 2014;15:2. https:\/\/doi.org\/10.1186\/1129-2377-15-2.","journal-title":"J Headache Pain"},{"key":"783_CR90","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/head.12162","volume":"54","author":"L Gallelli","year":"2014","unstructured":"Gallelli L, Avenoso T, Falcone D, et al. Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium. Headache. 2014;54:313\u201324. https:\/\/doi.org\/10.1111\/head.12162.","journal-title":"Headache"},{"key":"783_CR91","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ejpn.2016.12.009","volume":"21","author":"I Toldo","year":"2017","unstructured":"Toldo I, Rattin M, Perissinotto E, et al. Survey on treatments for primary headaches in 13 specialized juvenile headache centers: the first multicenter Italian study. Eur J Paediatr Neurol. 2017;21:507\u201321.","journal-title":"Eur J Paediatr Neurol"},{"issue":"03","key":"783_CR92","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1017\/S1481803500012276","volume":"12","author":"S Manzano","year":"2010","unstructured":"Manzano S, Doyon-Trottier E, Bailey B. Myth: ibuprofen is superior to acetaminophen for the treatment of benign headaches in children and adults. CJEM. 2010;12(03):220\u20132.","journal-title":"CJEM"},{"key":"783_CR93","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40272-013-0019-3","volume":"15","author":"\u00c7 W\u00f6ber-Bing\u00f6l","year":"2013","unstructured":"W\u00f6ber-Bing\u00f6l \u00c7. Pharmacological treatment of acute migraine in adolescents and children. Pediatr Drugs. 2013;15:235\u201346. https:\/\/doi.org\/10.1007\/s40272-013-0019-3.","journal-title":"Pediatr Drugs"},{"key":"783_CR94","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/archdischild-2016-311803","volume":"102","author":"WP Whitehouse","year":"2017","unstructured":"Whitehouse WP, Agrawal S. Management of children and young people with headache. Arch Dis Child-Educ Pract. 2017;102:58\u201365.","journal-title":"Arch Dis Child-Educ Pract"},{"key":"783_CR95","volume":"2015","author":"NP Barnes","year":"2015","unstructured":"Barnes NP. Migraine headache in children. BMJ Clin Evid. 2015;2015:0318.","journal-title":"BMJ Clin Evid"},{"key":"783_CR96","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1177\/0333102417736902","volume":"38","author":"M Jeric","year":"2018","unstructured":"Jeric M, Surjan N, Jelicic Kadic A, Riva N, Puljak L. Treatment of acute migraine attacks in children with analgesics on the World Health Organization essential medicines list: a systematic review and GRADE evidence synthesis. Cephalalgia. 2018;38:1592\u2013607. https:\/\/doi.org\/10.1177\/0333102417736902.","journal-title":"Cephalalgia"},{"key":"783_CR97","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1212\/WNL.48.1.103","volume":"48","author":"ML Hamalainen","year":"1997","unstructured":"Hamalainen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48:103\u20137. https:\/\/doi.org\/10.1212\/WNL.48.1.103.","journal-title":"Neurology"},{"key":"783_CR98","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/14737175.2022.2051481","volume":"22","author":"I Abu-Arafeh","year":"2022","unstructured":"Abu-Arafeh I. Predicting quality of life outcomes in children with migraine. Expert Rev Neurother. 2022;22:291\u20139. https:\/\/doi.org\/10.1080\/14737175.2022.2051481.","journal-title":"Expert Rev Neurother"},{"key":"783_CR99","doi-asserted-by":"publisher","first-page":"147","DOI":"10.13112\/pc.749","volume":"56","author":"N Bari\u0161i\u0107","year":"2012","unstructured":"Bari\u0161i\u0107 N, Prpi\u0107 I, Lehman I, Grdjan P, Re\u0161i\u0107 B. The Croatian Society of Pediatric Neurology guidelines for diagnosis and treatment of headaches in children. Paediatr Croat. 2012;56:147\u201355.","journal-title":"Paediatr Croat"},{"key":"783_CR100","unstructured":"ResearchGate. Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache. https:\/\/www.researchgate.net\/publication\/237287859_Guidelines_for_All_Healthcare_Professionals_in_the_Diagnosis_and_Management_of_Migraine_Tension-Type_Cluster_and_Medication-Overuse_Headache. Accessed 20 Aug 2025."},{"key":"783_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01228-4","volume":"22","author":"HW Schytz","year":"2021","unstructured":"Schytz HW, Amin FM, Jensen RH, et al. Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020. J Headache Pain. 2021;22:22. https:\/\/doi.org\/10.1186\/s10194-021-01228-4.","journal-title":"J Headache Pain"},{"key":"783_CR102","unstructured":"Overview | Headaches in over 12s: diagnosis and management | Guidance | NICE. NICE; 2012. https:\/\/www.nice.org.uk\/Guidance\/CG150. Accessed 26 Aug 2025."},{"key":"783_CR103","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1517\/14656566.2012.677434","volume":"13","author":"HL O\u2019Brien","year":"2012","unstructured":"O\u2019Brien HL, Kabbouche MA, Hershey AD. Treating pediatric migraine: an expert opinion. Expert Opin Pharmacother. 2012;13:959\u201366. https:\/\/doi.org\/10.1517\/14656566.2012.677434.","journal-title":"Expert Opin Pharmacother"},{"key":"783_CR104","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11940-016-0431-4","volume":"18","author":"K Merison","year":"2016","unstructured":"Merison K, Jacobs H. Diagnosis and treatment of childhood migraine. Curr Treat Options Neurol. 2016;18:48. https:\/\/doi.org\/10.1007\/s11940-016-0431-4.","journal-title":"Curr Treat Options Neurol"},{"key":"783_CR105","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/head.12746","volume":"56","author":"IR Patniyot","year":"2016","unstructured":"Patniyot IR, Gelfand AA. Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache. 2016;56:49\u201370. https:\/\/doi.org\/10.1111\/head.12746.","journal-title":"Headache"},{"key":"783_CR106","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jamaneurol.2019.4170","volume":"77","author":"CL Szperka","year":"2020","unstructured":"Szperka CL, VanderPluym JH, Oakley CB, American Medical Association. Pharmacologic acute and preventive treatment for migraine in children and adolescents. JAMA Neurol. 2020;77:388\u20139.","journal-title":"JAMA Neurol"},{"key":"783_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005220.pub2\/abstract","author":"L Richer","year":"2016","unstructured":"Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.CD005220.pub2\/abstract.","journal-title":"Cochrane Database Syst Rev"},{"key":"783_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.105853","volume":"195","author":"G Wang","year":"2020","unstructured":"Wang G, Tan T, Liu Y, Hong P. Drugs for acute attack of pediatric migraine: a network meta-analysis of randomized controlled trials. Clin Neurol Neurosurg. 2020;195:105853.","journal-title":"Clin Neurol Neurosurg"},{"key":"783_CR109","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s12098-020-03315-x","volume":"87","author":"V Pavithra","year":"2020","unstructured":"Pavithra V, Mishra D, Behera S, Juneja M. Paracetamol versus ibuprofen for the acute treatment of migraine headache in children: a blinded randomized controlled trial. Indian J Pediatr. 2020;87:781\u20136. https:\/\/doi.org\/10.1007\/s12098-020-03315-x.","journal-title":"Indian J Pediatr"},{"key":"783_CR110","doi-asserted-by":"publisher","first-page":"278","DOI":"10.12701\/jyms.2022.00528","volume":"39","author":"S Kim","year":"2022","unstructured":"Kim S. Pediatric headache: a narrative review. J Yeungnam Med Sci. 2022;39:278\u201384.","journal-title":"J Yeungnam Med Sci"},{"key":"783_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11467-3","volume":"12","author":"J Genizi","year":"2022","unstructured":"Genizi J, Lahoud D, Cohen R. Migraine abortive treatment in children and adolescents in Israel. Sci Rep. 2022;12:7418.","journal-title":"Sci Rep"},{"key":"783_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153420","volume":"10","author":"U Freo","year":"2021","unstructured":"Freo U, Ruocco C, Valerio A, Scagnol I, Nisoli E. Paracetamol: a review of guideline recommendations. J Clin Med. 2021;10:3420. https:\/\/doi.org\/10.3390\/jcm10153420.","journal-title":"J Clin Med"},{"issue":"S1","key":"783_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10194-011-0402-9","volume":"13","author":"L Bendtsen","year":"2012","unstructured":"Bendtsen L, Birk S, Kasch H, et al. Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd edition, 2012. J Headache Pain. 2012;13(S1):1\u201329. https:\/\/doi.org\/10.1007\/s10194-011-0402-9.","journal-title":"J Headache Pain"},{"key":"783_CR114","doi-asserted-by":"publisher","first-page":"680","DOI":"10.5863\/1551-6776-28.8.680","volume":"28","author":"KV Blake","year":"2023","unstructured":"Blake KV. Ethics challenges in pediatric research. J Pediatr Pharmacol Ther. 2023;28:680\u20136. https:\/\/doi.org\/10.5863\/1551-6776-28.8.680.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"783_CR115","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.braindev.2016.11.011","volume":"39","author":"Y Saito","year":"2017","unstructured":"Saito Y, Yamanaka G, Shimomura H, et al. Reconsideration of the diagnosis and treatment of childhood migraine: a practical review of clinical experiences. Brain Dev. 2017;39:386\u201394. https:\/\/doi.org\/10.1016\/j.braindev.2016.11.011.","journal-title":"Brain Dev"},{"key":"783_CR116","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/head.13438","volume":"59","author":"AMK Van Diest","year":"2019","unstructured":"Van Diest AMK, Powers SW. Cognitive behavioral therapy for pediatric headache and migraine: why to prescribe and what new research is critical for advancing integrated biobehavioral care. Headache. 2019;59:289\u201397. https:\/\/doi.org\/10.1111\/head.13438.","journal-title":"Headache"},{"key":"783_CR117","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/head.13016","volume":"57","author":"QX Ng","year":"2017","unstructured":"Ng QX, Venkatanarayanan N, Kumar L. A systematic review and meta-analysis of the efficacy of cognitive behavioral therapy for the management of pediatric migraine. Headache. 2017;57:349\u201362. https:\/\/doi.org\/10.1111\/head.13016.","journal-title":"Headache"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00783-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-025-00783-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00783-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:20:53Z","timestamp":1763634053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-025-00783-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":117,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1007\/s40122-025-00783-x","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"type":"print","value":"2193-8237"},{"type":"electronic","value":"2193-651X"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Christopher Oakley has received honoraria from the Southern Headache Society and American Academy of Pediatrics; receives royalties from Springer (for\n                      Pediatric Headache\n                      , 1st ed. manuscript); is a board member of the Southern Headache Society; on the Examination Committee and Accreditation Committee UCNS \/ Headache Medicine. Preeti Kachroo is an employee of Haleon PLC. Ashoke Mitra is an employee of Haleon PLC; holds stock or stock options with Haleon. John Bell is a consultant for Bayer, GlaxoSmithKline, Mylan, Novartis, Pfizer, Procter and Gamble. Reckitt Benckiser has received support from Bayer, Haleon, Mylan, Procter and Gamble; participated in data safety monitoring or ad board for GlaxoSmithKline; has received honoraria and support from iNova, GlaxoSmithKline, Pfizer, and Reckitt Benckiser; holds a leadership\/fiduciary role in The Pharmaceutical Society of Australia and The Australian Self Care Alliance; and has financial\/non-financial interests in The University of Technology Sydney.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}